Statera Biopharma, Inc.

Statera Biopharma, Inc. logo
🇺🇸United States
Ownership
Public
Established
2014-01-01
Employees
16
Market Cap
-
Website
http://www.staterabiopharma.com

Treatment of Advanced Renal Cell Carcinoma With Quinacrine

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2007-12-17
Last Posted Date
2015-08-03
Lead Sponsor
Cleveland BioLabs
Registration Number
NCT00574483
Locations
🇺🇸

Community Care Physicians, Albany, New York, United States

🇺🇸

ClinWorks Cancer Research Center, Charlotte, North Carolina, United States

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2006-12-29
Last Posted Date
2013-04-11
Lead Sponsor
Cleveland BioLabs
Target Recruit Count
31
Registration Number
NCT00417274
© Copyright 2024. All Rights Reserved by MedPath